DAWN
Price
$7.38
Change
-$0.13 (-1.73%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
769.26M
69 days until earnings call
UTHR
Price
$404.56
Change
+$99.80 (+32.75%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
13.78B
57 days until earnings call
Interact to see
Advertisement

DAWN vs UTHR

Header iconDAWN vs UTHR Comparison
Open Charts DAWN vs UTHRBanner chart's image
Day One Biopharmaceuticals
Price$7.38
Change-$0.13 (-1.73%)
Volume$27.73K
Capitalization769.26M
United Therapeutics
Price$404.56
Change+$99.80 (+32.75%)
Volume$32.87K
Capitalization13.78B
DAWN vs UTHR Comparison Chart in %
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. UTHR commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Buy and UTHR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (DAWN: $7.51 vs. UTHR: $304.76)
Brand notoriety: DAWN and UTHR are both not notable
DAWN represents the Biotechnology, while UTHR is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: DAWN: 53% vs. UTHR: 73%
Market capitalization -- DAWN: $758M vs. UTHR: $18.31B
DAWN [@Biotechnology] is valued at $758M. UTHR’s [@Pharmaceuticals: Generic] market capitalization is $18.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.75B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 1 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • DAWN’s FA Score: 1 green, 4 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 7 TA indicator(s) are bullish while UTHR’s TA Score has 7 bullish TA indicator(s).

  • DAWN’s TA Score: 7 bullish, 2 bearish.
  • UTHR’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than UTHR.

Price Growth

DAWN (@Biotechnology) experienced а +4.31% price change this week, while UTHR (@Pharmaceuticals: Generic) price change was -2.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.73%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +83.70%.

Reported Earning Dates

DAWN is expected to report earnings on Nov 10, 2025.

UTHR is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+0.73% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.8B) has a higher market cap than DAWN($769M). UTHR YTD gains are higher at: -13.627 vs. DAWN (-40.726). UTHR has higher annual earnings (EBITDA): 1.73B vs. DAWN (-108.37M). UTHR has more cash in the bank: 3.05B vs. DAWN (453M). DAWN has less debt than UTHR: DAWN (3M) vs UTHR (200M). UTHR has higher revenues than DAWN: UTHR (3.08B) vs DAWN (188M).
DAWNUTHRDAWN / UTHR
Capitalization769M13.8B6%
EBITDA-108.37M1.73B-6%
Gain YTD-40.726-13.627299%
P/E RatioN/A11.89-
Revenue188M3.08B6%
Total Cash453M3.05B15%
Total Debt3M200M2%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNUTHR
RSI
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 5 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
70%
Momentum
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
58%
MACD
ODDS (%)
Bullish Trend 5 days ago
78%
Bearish Trend 5 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
68%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 12 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
65%
Aroon
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IYG89.690.12
+0.13%
iShares US Financial Services ETF
SEPM31.27N/A
+0.01%
FT Vest U.S. Eq Max Buffr ETF - Sep
ACTV32.98-0.13
-0.39%
LeaderShares® Activist Leaders® ETF
PDN40.51-0.17
-0.41%
Invesco RAFI Developed Mkts ex-US S-METF
FCVT40.40-0.34
-0.85%
First Trust SSI Strat Convert Secs ETF

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-1.05%
DNLI - DAWN
50%
Loosely correlated
-2.43%
RVMD - DAWN
50%
Loosely correlated
-0.93%
SYRE - DAWN
49%
Loosely correlated
-1.38%
NRIX - DAWN
49%
Loosely correlated
-0.74%
IDYA - DAWN
48%
Loosely correlated
-1.52%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-0.81%
DAWN - UTHR
40%
Loosely correlated
-1.05%
MNKD - UTHR
38%
Loosely correlated
+2.23%
GERN - UTHR
37%
Loosely correlated
-2.10%
CERO - UTHR
33%
Poorly correlated
-1.96%
UNCY - UTHR
32%
Poorly correlated
-0.24%
More